|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.05 USD | -2.15% |
|
+5.03% | +13.61% |
| 06-30 | Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing | MT |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZAI LAB LIMITED | Biopharmaceuticals | -2.15% | +5.03% | +13.61% | -41.54% | -88.28% | 2.3B |  |  | |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
